You can view it here in a better format!
http://docs.google.com/View?id=ddb246wq_9f8qm94
Parasympathetic Nervous System
Cholinoreceptor:
G protein-linked (Muscarinic): CNS, PNS-targeted tissues, vascular endothelium (not innervated by CNS)
- seven transmembrane domains (third cytoplasmic loop is coupled to G proteins)
M1 & M3: Gq everything except heart → activates the IP3, DAG cascade = ↑ Ca2+
M2 & M4: Giα → heart, inhibits adenylyl cyclase activity (inhibit cAMP & Giβ = ↑K+ flux)
Ion channel (nicotinic): “Neuronal” - ANS postganglions, some CNS neurons; “NMJ” - somatic motor fibers innervating muscles
- 4 subunits form cation-selective ion channels→ electrical and ionic changes→ depolarization
*Prolonged agonist occupancy→ "depolarizing blockade" abolishes the effector response→ can produce muscle paralysis
Direct Muscarinic Agonists:
CV: Direct effect = vasoconstriction; masked by NO-mediated vasodilation (requires intact endothelium) → reflex tachycardia
Pulm: Bronchoconstriction, ↑mucus secretion, *exacerbates asthma
GIT: ↑secretions (salivary, gastric, pancreatic & intestinal) & ↑peristalsis (contract longitudinal muscle while relaxing sphincters)
GUT: Promotes voiding: Detrusor contraction, relax trigone & sphincters
Eye: Miosis (iris contraction), Accommodation (ciliary contraction - facilitates aqueous humor outflow)
Secretory: ↑ secretion by thermoregulatory sweat glands (anomalous Muscarinic receptors of SNS)
Choline Esters - poorly absorbed & poorly distributed into CNS
Acetylcholine [Endogenous transmitter] – rapidly hydrolyzed - Affects both Muscarinic & nicotinic receptors
Low Dose: mostly vascular Muscarinic receptors→ NO→ vasodilation→ reflex tachycardia; cardiac effects hidden by baroreceptor response
High Dose: vascular + direct bradycardia (potential atrial flutter) * Can evoke SNS response thru ganglia (see when using Muscarinic antag)
Methacholine - Slightly resistant to AChE - Specific to Muscarinic (methyl group reduces potency @ nicotinic)
Bethanechol - Resistant to degradation by AChE - Specific to Muscarinic (methyl group reduces potency @ nicotinic)
Carbachol - Resistant to degradation by AChE
- Affects both Muscarinic & nicotinic receptors (i.e. can cause endogenous ACh release through ganglionic nicotinic receptors)
Alkaloids
Muscarine - Fungal (4° amine) alkaloid ACh mimetic
- Activates Muscarinic receptors, CNS activity
- Resistant to AChE
- No therapeutic use
Pilocarpine (ophthalmic) – (natural 3° amine) alkaloid ACh mimetic
- Used to treat glaucoma by allowing for fluid drainage from eye & atropine poisoning
- Resistant to AChE
Muscarinic Receptor Antagonists: Block action of ACh/agonists at Muscarinic receptors;
CNS: Minimal effects – Toxic doses→ agitation, hallucinations & coma; often used w/ dopamine precursor in Parkinson’s, also relieves vagal syncope
CV: Tachycardia (blocks PNS tone @ SA node), few hemodynamic effects
Pulm: Bronchodilation & ↓mucus secretion (not as useful as B2 agonists in asthma)
GIT: ↓motility & secretions – useful for mild GI hypermotility, excessive salivation, or as pre-op adjuvant before abdominal surgery
GUT: can cause urinary retention, especially w/ BPH
Eye: Mydriasis (dilated pupils); Cycloplegia (paralyzed ciliary muscle) – good for ophthalmic exam; Acute glaucoma (narrow anterior chamber angle)
Secretory: “atropine fever” - ↓ thermoregulatory sweating (anomalous Muscarinic receptors of SNS); helpful in hyperhidrosis
Contraindications: Glaucoma (especially closed angle), Prostatic hyperplasia, may ↑ gastric ulcer symptoms
3° Amine – Used for effects in eye or CNS
Atropine [Prototype] – reversible (competitive) blockade with relatively long duration of action; non-selective between M1, 2 & 3
- classic antidote to organophosphate poisoning
- “Atropine Poisoning”: dry (as a bone) mouth, mydriasis (blind as a bat), tachycardia, flushed skin (red as a beet), delirium (mad as a hatter)
Treat with Physostigmine or symptom management
Scopolamine - has a relatively long duration of action, better CNS, motion sickness
Homatropine
Pirenzepine - M1-selective (nerves)
Tropicamide
Tolterodine - M3-selective (urinary urgency, frequency & incontinence)
4° Amine – Only peripheral effects, cannot penetrate CNS (due to charge) – NOT used to reverse cholinergic poisoning
Atropine Methyl Nitrate
Methscopolamine
Ipratropium - asthma
Propantheline
Glycopyrrolate
Indirect Cholinomimetics: ACh-esterase inhibitors (also inhibit ButyrylCh-esterase) → amplify effect of endogenous ACh (modifies PNS tone)
Prominent effects on CV, GIT, eye & skeletal muscle; but NO effect on peripheral vasculature
@ NMJ: low conc. → ↑force of contraction; high conc. →depolarizing neuromuscular blockade
Clinical Uses: Atropine or TCA (tricyclic antidepressant) intoxication/overdose
CNS: Mild to moderate Alzheimer’s disease
GIT & GUT: ↑smooth muscle activity – postop ileus, congenital megacolon, reflux esophagitis, neurogenic bladder, urinary retention
Eye: Glaucoma (closed angle) - ciliary contraction →↑ aqueous humor outflow→ ↓intraocular pressure
NMJ: Myasthenia Gravis
Toxicity: SLUDGE = Salivation, Lactation, Urinary incontinence, Diarrhea, Gastrointestinal cramps & Emesis – reversed by atropine (& 2-PAM)
Simple Alcohol Esters (simple alcohols bearing a 4° ammonium group)
Edrophonium – [very short half-life] - Diagnostic Test for myasthenia gravis
Carbamates (carbamic acid esters of alcohols bearing 3° or 4° ammonium group)
* Undergo 2-step hydrolysis (covalent bond formed w/ enzyme is resistant to hydration; inhibition is longer (30 minutes - 6 hours)
Ambenonium (Mestinon)
Carbaryl – high lipid solubility (rapid CNS effects)
Demecarium- Used to treat glaucoma
Neostigmine – (4° amine - permanent charge renders them relatively insoluble in lipids – poor absorption/CNS distribution)
* Used to treat myasthenia gravis, ileus (severe abdominal cramping due to obstruction)
* Has both indirect & direct effects in PNS (inhibits AChE & stimulated Muscarinic receptors)
Physostigmine – (3° amine - well absorbed, CNS distribution); duration of effect is determined by stability of inhibitor-enzyme complex
- Used to treat glaucoma, myasthenia gravis & atropine overdose
Pyridostigmine - Used to treat myasthenia gravis
Organophosphates - well absorbed topically w/ good CNS distribution (except Echo); * Before aging, pralidoxime (2-PAM) can restore enzyme fxn
bind→ hydrolyzed/phosphorylated AChe active site – extreme stability (strengthened by “Aging”) → lifetime inhibition
Diisoprophylfluorophosphate (DFP) - Can cause cumulative overdose due to extremely long duration of action
Donepezil
Echothiophate – poorly absorbed, very long half-life (~100 minutes) - Used to treat glaucoma
Isoflurophate (ophthalmic) - Used to treat glaucoma
Malathion – [irreversible] - converted to phosphate derivative, used as insecticide
Parathion – [irreversible] – converted to phosphate derivative (Active only after biotransformation), used as insecticide
Sarin
Soman - Immediately & completely binds AChE (no aging) - Potential biological weapon
Tacrine - anticholinesterase and cholinomimetic actions – used for mild/moderate Alzheimer’s disease
Cholinesterase Regenerator
Pralidoxime (2-PAM)
Direct Nicotinic Agonist: Mostly targets ganglia; ↑SNS & PSNS: predominant tone determines effect (SNS = vasculature, PSNS = everything else)
Toxicity: CNS stimulation→ convulsion, coma, resp arrest (NMJ depolarization block); HTN & arrhythmias – Tx w/ Muscarinic Antag. & mech. resp
Nicotine – (natural 3° amine)
Lobeline – (natural 3° amine) a plant derivative similar to nicotine
Ganglion-Blockers (Nicotinic Antagonists): Block action of ACh/agonists at nicotinic receptors in SNS & PSNS ganglia; All are synthetic amines
Blocks homeostatic reflexes (e.g. baro & sweating), but effector cell receptors are NOT blocked; End-Organ effects depend on predominant ANS tone
CV: ↓SNS tone→↓BP & orthostatic hypotension (no baro); ↓PSNS tone @ SA node→ mild tachycardia
GIT: ↓PSNS tone→↓secretions & motility→ constipation & xerostomia (dry mouth)
GUT: Hesitancy or urinary retention (esp. with Prostatic hyperplasia); Impaired sexual function (requires both SNS & PSNS)
Eye: ↓PSNS tone→ cycloplegia (paralyzed ciliary muscle) & moderate pupil dilation (Normal Input: PSNS>SNS)
Tetraethylammonium (TEA) [prototype] - short half-life; used to manage HTN
Hexamethonium
- No therapeutic use currently
Mecamylamine – readily enters CNS→ sedation, tremor, choreiform movements, mental aberrations
Trimethaphan (IV) – 4° Amine →lacks CNS effects
- Extremely short acting
- Can be used to treat acute dissecting aneurysm or autonomic hyperreflexia
Sympathetic Nervous System
Adrenergic Neuron Blockers:
Reserpine - non-selective blocker of uptake & storage of amines
Guanadrel - similar to reserpine
Adrenoreceptor Agonists:
A1- forms IP3, DAG & activates phospholipase C; A2 - presynaptic autoregulation of SNS outflow, inhibits cAMP formation
B1 & B2 - activates adenyl cyclase;
CV: A1→ vasoconstriction, ↓renin secretion; B1 – Ca++ influx into cells (↑ino & chronotropic), ↑renin secretion
Pulm: A1in vessels of URT mucosa→ contraction→decongestion
GIT: A2→↓PNS tone on enteric system; Beta on smooth muscle mediates relaxation
GUT: A1→contract bladder base & urethral sphincter; B2→relax bladder wall smooth muscles – both actions promote urinary retention
Eye: Alpha→ radial dilator contraction→ mydriasis (dilated pupil); Beta→↑aqueous humor production by ciliary epithelium→ ↑intraocular pressure
Exocrine: A1 on aprocrine (stress) sweat glands→ sweating on palms, brow & upper lip
Metabolic: A2→↓ insulin release; Beta→ ↑lipolysis, ↑glycogenolysis, ↑glucose release, ↑insulin secretion
Toxicity: Extended effects – hypertension, tachycardia, CNS – restless, tremor, insomnia, anxiety, paranoia
Catecholamines:
Epinephrine – A1, A2; B1, B2: skeletal muscle arteriodilation & ↑venous capacity (mixed TPR effects)
Norepinephrine - A1: ↑TPR, A2; B1: Heart effects overcome by vagal reflex; = ↑Sys, Dias; High doses = ↑HR
Isoproterenol - B1= ↑CO; B2: skeletal muscle arteriodilation & ↑venous capacity = ↓Dias & MAP
Dolbutamine (B1; A1 @ high doses) - Uses: Heart failure/cardiac decompensation (short-term) – limited by tolerance/desensitization
Dopamine - D1 stimulates adenyl cyclase in renal vasculature→ renal vasodilation→ ↑GFR; A1; B1 @ high doses
Alpha-1 Specific – mydriasis (fundoscopic exam) & decongestant, can ↑BP;
Uses: nasal congestion, hypotension, paroxysmal atrial tachycardia
Phenylephrine [prototype] – not a catechol derivative, thus not inactivated by MAO/COMT; longer duration of action
Methoxamine
Oxymetazoline & Xylometazoline – used as topical decongestants
Alpha-2 Specific – Use as anti-HTN
Clonidine
Methyldopa
Guanfacine
Guanabenz
Beta-1 Specific – ↑CO w/ less reflex tachycardia;
Dolbutamine
Prenalterol (partial)
Beta-2 Specific – bronchodilation; Uses: Asthma & bronchial constriction
Albuterol
Salmeterol
Terbutaline
Ritodrine - uterine relaxation in premature labor
Indirect Sympathomimetics:
Ephedrine – first orally active
Pseudoephedrine [also direct] – cause release of endogenous NE; widely available OTC decongestant
Cocaine - block uptake1 (potentiates effects of NE) - Used as local anesthetic
Tyramine – enter thru uptake1, displace stored catecholamines→ hypertensive crisis; potentiated by MAO inhibitors * fermented foods (cheese)
Amphetamine (NOT a catecholamine) – mech=same as tyramine; ↑mood & alertness; ↓appetite *Common Drug of Abuse – Used for narcolepsy
Methamphetamine – similar, but w/ ↑ratio of central to peripheral effects
Methylphenidate - used to treat ADHD
Adrenoreceptor Blockers:
Alpha Receptor Antagonists - * Nitrates are preferred in hypertensive crises
Non-selective Alpha Antagonists
Phentolamine [prototype] – reversible, competitive; ↓TPR & MAP→reflex tachycardia
Tolazoline – similar to phentolamine;
Phenoxybenzamine – irreversible, slightly alpha-1 selective; Uses: Pheochromocytoma, limited by postural hypotension & reflex tachycardia
*Excessive release of NE & Epi from adrenal medulla
Alpha-1 Selective Antagonists: Uses: HTN & BPH - ↓TPR & BP, May cause postural hypotension & reflex tachycardia
Prazosin
Terazosin
Trimazosin
Doxazosin – longer half-life
Tamsulosin & Alfuzosin – competitive; Uses: BPH (prostate subtype selectivity)
Labetalol - also non-specific beta blocker
Alpha-2 Selective Antagonists
Yohimbine - no established clinical role, has been used in ED
Beta Receptor Antagonists – well absorbed orally
CV: ↓SNS tone to heart → slower AV conduction & ↓BP, but NOT hypotension; ↓SNS tone to kidney→ ↓renin secretion
Pulm: B2 block→ ↑airway resistance
Eye: ↓aqueous humor production by ciliary epithelium→ ↓intraocular pressure
Metabolic/Endocrine: ↓SNS stimulation of lipolysis & glycogenolysis; Use with caution in IDDM patients; Chronic use→ ↑VLDL & ↓HDL
Clinical Uses: HTN (w/ diuretic or vasodilator);
Ischemic Heart Disease - ↓angina frequency, cardiac work/oxygen demand; improves exercise tolerance; prolongs post-MI survival
Cardiac Arrhythmias (atrial & ventricular) - ↑AV refractory period, ↓ventricular response in A-fib, ↓ventricular ectopic beats
Glaucoma – refer to Eye above, better tolerated than Epi or Pilocarpine in open-angle glaucoma
Hyperthyroidism – limits excessive catecholamine activity
Toxicity: Minor= F, rash, depression, sedation; Major= exacerbates asthma, cardiac decompensation, supersensitivity (taper), hypoglycemia in IDDM
Non-selective Beta Antagonists - used to treat: HTN, angina, arrhythmias, glaucoma, and migraine; do NOT use in asthmatics
Propranolol [prototype] – extensive hepatic (first-pass) metabolism, low bioavailability
Nadolol – very long duration of action
Timolol – very long duration of action
Partial Agonists – may prevent bradycardia, changes in lipid profile & precipitation of asthma
Dichloroisoproterenol – first beta-blocking drug
Pindolol
Cartelolol
Penbutolol
Labetalol – reversible alpha-1 antagonist; → hypotension w/ less tachycardia than alpha-blockers
Beta-1 Selective Antagonists - treat HTN; Can also ↑airway resistance when used in asthmatics
Metoprolol
Esmolol – rapid hydrolysis by esterases in RBCs: half-life = 10 min.
Atenolol
Acebutolol – intrinsic sympathomimetic effects
Betaxolol
Bisoprolol
Beta-2 Selective Antagonists
Butoxamine - no clinical use
Some ANS pharm review
Posted by
dr4ku
Tuesday, June 9, 2009
Labels: ANS , exam , med student , Pharmacology , Review , Step 1 , USMLE
0 comments:
Post a Comment